August 18, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, ...

When Robert Stone thinks about what makes City of Hope stand apart, it's the people. He recalls a patient who stopped him, a ...

The fate of an important breakthrough in cancer immunotherapy treatment remains in the balance following an announcement ...

A team of scientists at the Garvan Institute of Medical Research has discovered that inactivation of a stress pathway makes ...

Stage-four cancer patients are living longer, challenging the idea of what it means to have and survive cancer. “The science ...

Research has shown that there is a high rate of cannabis use among cancer patients — more than 50% in some studies, and up to ...

A new drug-releasing system, TAR-200, eliminated tumors in 82% of patients in a phase 2 clinical trial for individuals with ...

Cancer remains one of the most challenging diseases to treat, as conventional therapies like chemotherapy and radiotherapy are often hindered by poor specificity, systemic toxicity, and damage to ...

Fourth Cohort Receiving 30x Initial Dose with No Dose-Limiting Toxicities Observed to Date SAN JOSE, Calif., Aug. 18, 2025 /PRNewswire/ -- Anixa Biosciences, Inc.

After chemotherapy, some people get "chemo curls" and other changes to their hair texture and appearance. But why?

Research shows that having a first child after age 30 increases a woman’s risk of breast cancer by 40 per cent to 45 per cent ...